- Home
- EBC vs RLAY Comparison
EBC vs RLAY Comparison
Compare EBC & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EBC | RLAY |
|---|---|---|
| Founded | 1818 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.1B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EBC | RLAY |
|---|---|---|
| Price | $22.96 | $19.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 10 |
| Target Price | ★ $22.70 | $19.50 |
| AVG Volume (30 Days) | 4.2M | ★ 4.2M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.02% | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $134,091,000.00 | $15,355,000.00 |
| Revenue This Year | $80.92 | N/A |
| Revenue Next Year | $4.44 | $324.03 |
| P/E Ratio | $80.88 | ★ N/A |
| Revenue Growth | 19.07 | ★ 53.44 |
| 52 Week Low | $14.88 | $3.03 |
| 52 Week High | $23.54 | $20.79 |
Technical Indicators
Market Signals| Indicator | EBC | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 63.17 | 62.76 |
| Support Level | $19.12 | $12.10 |
| Resistance Level | N/A | $20.79 |
| Average True Range (ATR) | 0.51 | 1.31 |
| MACD | 0.04 | -0.09 |
| Stochastic Oscillator | 70.59 | 73.40 |
Price Performance
Historical ComparisonAbout EBC Eastern Bankshares Inc.
Eastern Bankshares Inc is a commercial bank that caters its products and services to retail, commercial, and small business customers. Its diversified products and services include lending, deposit, wealth management, and insurance products. The company has one operating segment: Banking business, which offers a range of banking, lending, savings, and small business offerings, and its wealth management and trust operations.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.